EVKIF Stock Chart & Stats
$22.42
-$1.39(-6.92%)
At close: 4:00 PM EDT
$22.42
-$1.39(-6.92%)
Day’s Range― - ―
52-Week Range$14.49 - $24.13
Previous CloseN/A
Volume200.00
Average Volume (3M)57.00
Market Cap
$10.98B
Enterprise Value$11.54B
Total Cash (Recent Filing)$390.00M
Total Debt (Recent Filing)$4.46B
Price to Earnings (P/E)81.6
Beta0.44
Next Earnings
Nov 03, 2026EPS Estimate
0.6Next Dividend Ex-DateN/A
Dividend Yield5.01%
Share Statistics
EPS (TTM)0.26
Shares Outstanding466,000,000
10 Day Avg. Volume110
30 Day Avg. Volume57
Financial Highlights & Ratios
PEG Ratio1.25
Price to Book (P/B)0.77
Price to Sales (P/S)0.44
P/FCF Ratio8.96
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue0.82
Enterprise Value/Gross Profit3.68
Enterprise Value/Ebitda5.46
Forecast
1Y Price Target
$21.13Price Target Upside-5.76% Downside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.91
Revenue Forecast (FY)$16.47B
Bulls Say, Bears Say
Bulls Say
Resilient Cash GenerationStrong operating and free cash flow provide internal funding for investment, debt service, and shareholder returns. Positive free cash flow even during the 2023 loss year demonstrates better cash conversion and greater resilience than reported net income alone.
Manageable Balance-sheet LeverageA manageable debt burden and substantial equity base give Evonik financial flexibility across the specialty-chemicals cycle. This supports continued operations and investment while reducing the risk that leverage alone constrains strategic choices over the next several quarters.
Differentiated Specialty-chemicals PortfolioEvonik’s specialty products are embedded in customer formulations and applications spanning healthcare, nutrition, mobility, and industrial markets. Qualification requirements, application support, and proprietary process know-how can encourage recurring demand and support differentiation over time.
Bears Say
Weak Multi-year Revenue TrendLimited revenue momentum indicates that end-market demand and pricing have not yet produced durable top-line expansion. Several flat-to-down years can restrict operating leverage, reduce room for reinvestment, and make future earnings more dependent on mix and efficiency actions.
Thin And Volatile ProfitabilityVery thin net profitability leaves limited buffer against cost pressure, weaker demand, or unfavorable product mix. The prior loss and continuing earnings volatility also reduce confidence in sustainable returns, even though EBITDA and EBIT margins remain positive for the sector.
Low Returns With Rising LeverageLow returns on equity suggest that the capital base is not currently generating strong shareholder earnings. At the same time, higher debt and reduced equity modestly weaken the balance-sheet trajectory, potentially limiting flexibility if operating performance remains uneven.
Evonik News
EVKIF FAQ
What was Evonik’s price range in the past 12 months?
Evonik lowest stock price was $14.49 and its highest was $24.13 in the past 12 months.
What is Evonik’s market cap?
Evonik’s market cap is $10.98B.
When is Evonik’s upcoming earnings report date?
Evonik’s upcoming earnings report date is Nov 03, 2026 which is in 21 days.
How were Evonik’s earnings last quarter?
Evonik released its earnings results on Aug 04, 2026. The company reported $0.726 earnings per share for the quarter, beating the consensus estimate of $0.618 by $0.108.
Is Evonik overvalued?
According to Wall Street analysts Evonik’s price is currently Overvalued.
Does Evonik pay dividends?
Evonik pays a Annually dividend of $1.153 which represents an annual dividend yield of 5.01%. See more information on Evonik dividends here
What is Evonik’s EPS estimate?
Evonik’s EPS estimate is 0.6.
How many shares outstanding does Evonik have?
Evonik has 466,000,000 shares outstanding.
What happened to Evonik’s price movement after its last earnings report?
Evonik reported an EPS of $0.726 in its last earnings report, beating expectations of $0.618. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Evonik?
Currently, no hedge funds are holding shares in EVKIF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Evonik Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$21.13 (-5.76% Downside)
$21.13 (-5.76% Downside)
Blogger Sentiment
Bullish
EVKIF Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.48%
12-Months-Change
Fundamentals
Return on Equity
1.49%
Trailing 12-Months
Asset Growth
-2.30%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Evonik
Evonik Industries AG operates primarily in the specialized chemicals market. Its business activities are structured across five principal divisions: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment is responsible for delivering essential ingredients such as polyurethane additives, modified silicones, isophorones, epoxy hardeners, oil modifiers, fumed silicas, matting agents, TAA compounds, and acetylenic diol-based surfactants, which find use in consumer products and various industrial applications. In the Nutrition & Care division, Evonik provides compounds like amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and their derivatives, synthetic products, pharmaceutical-grade polymers, and DL-methionine. These are crucial for consumer goods, animal nutrition, and healthcare industries. The Smart Materials segment manufactures advanced substances including hydrogen peroxide, peracetic acid, various activated nickel and precious metal catalysts (for powder, oil, and fat hydrogenation), amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, and different types of silicas (fumed and precipitated). These serve a broad spectrum of industries including automotive, paints, coatings, adhesives, and construction. Through its Performance Materials segment, the company produces polymer materials and intermediate chemicals, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbents, specifically for the rubber, plastics, and automotive sectors. Lastly, the Technology & Infrastructure segment provides crucial internal services, encompassing site management, utilities and waste disposal, technical expertise, process technology, engineering, and logistics. Evonik maintains a significant international presence, with operations spanning across the Asia-Pacific region, Europe, the Middle East, Africa, Central and South America, and North America. Founded in 1873, the firm's main offices are located in Essen, Germany, and it functions as a subsidiary of RAG-Stiftung.
EVKIF Stock 12 Month Forecast
Average Price Target
$21.13
▼(-5.76% Downside)
Technical Analysis
Ownership Overview
― Insiders
7.81% Mutual Funds
<0.01% Other Institutional Investors
81.59% Public Companies and
Individual Investors